Heart transplantation during active infective endocarditis: Case report and review of the literature

Transplantation Proceedings

Volumn 43, Issue 1, 2011, Pages 304-306

  Durante Mangoni, E ^a,b   Casillo, R ^a,b   Pinto, D ^a,b   Caianiello, C ^a,b   Albisinni, R ^a,b   Caprioli, V ^b   Maiello, C ^b   Utili, R ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b MONALDI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DAPTOMYCIN; EVEROLIMUS; METHYLPREDNISOLONE; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; CARDIAC RESYNCHRONIZATION THERAPY; CASE REPORT; CONFERENCE PAPER; DISEASE COURSE; DRUG MEGADOSE; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; ENDOCARDITIS, BACTERIAL; FEMALE; HEART TRANSPLANTATION; HUMANS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 79951807932     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.09.095     Document Type: Conference Paper

References (16)

1. Mehra MR, Kobashigawa J, Starling R, et al: Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates - 2006. J Heart Lung Transplant 25:1024, 2006
2. Macdonald P: Heart transplantation: who should be considered and when? Intern Med J 38:911, 2008
3. Pavie A: Heart transplantation for end-stage valvular disease: indications and results. Curr Opin Cardiol 21:100, 2006
4. Habib G, Hoen B, Tornos P, et al: Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 30:2369, 2009
5. DiSesa VJ, Sloss LJ, Cohn LH: Heart transplantation for intractable prosthetic valve endocarditis. J Heart Transplant 9:142, 1990
6. Park SJ, Sullivan HJ, Lonchyna V, et al: Heart transplantation for complicated and recurrent early prosthetic valve endocarditis. J Heart Lung Transplant 12:802, 1993
7. Pulpon LA, Crespo MG, Sobrino M, et al: Recalcitrant endocarditis successfully treated by heart transplantation. Am Heart J 127:958, 1994
8. Galbraith AJ, McCarthy J, Tesar PJ, et al: Cardiac transplantation for prosthetic valve endocarditis in a previously transplanted heart. J Heart Lung Transplant 18:805, 1999
9. Blanche C, Freimark D, Valenza M, et al: Heart transplantation for Q fever endocarditis. Ann Thorac Surg 58:1768, 1994
10. Cabell CH, Heidenreich PA, Chu VH, et al: Increasing rates of cardiac device infections among Medicare beneficiaries 1990-1999. Am Heart J 147:582, 2004
11. Voigt A, Shalaby A, Saba S: Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol 48:590, 2006
12. Sohail MR, Uslan DZ, Khan AH, et al: Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 45:166, 2007
13. Baddour LM, Epstein AE, Erickson CC, et al: Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 121:458, 2010
14. Jones SO IV, Eckart RE, Albert CM, et al: Large, single-center, single-operator experience with transvenous lead extraction: outcomes and changing indications. Heart Rhythm 5:520, 2008
15. Bongiorni MG, Soldati E, Zucchelli G, et al: Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads. Eur Heart J 29:2886, 2008
16. Smith MC, Love CJ: Extraction of transvenous pacing and ICD leads. Pacing Clin Electrophysiol 31:736, 2008